Fri, March 24, 2023

Arthur He Maintained (BCAB) at Strong Buy with Decreased Target to $17 on, Mar 24th, 2023

Arthur He of HC Wainwright & Co., Maintained "BioAtla, Inc." (BCAB) at Strong Buy with Decreased Target from $20 to $17 on, Mar 24th, 2023.

Arthur, nor any peers, have made any analyst calls on BCAB in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30